anti-TCR monoclonal antibodies
/ Medigene, German Research Center for Environmental Health, Max Delbrück Centre for Molecular Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 25, 2016
Medigene expands TCR platform technology with US patent for method for identification of CD4+ T cell antigens
(MediGene Press Release)
- "Medigene...announces the grant of US patent US9,341,617B2. The patent, with an expected life-span until 2030, claims a method for the identification of antigens recognized by CD4+ T cells, including tumor infiltrating CD4+ T cells...Medigene holds an exclusive license to the patent that was issued to Helmholtz Zentrum München (German Research Center for Environmental Health)."
Anticipated patent expiry • Patent • Oncology
1 to 1
Of
1
Go to page
1